FFAGLDD TFA
FFAGLDD TFA is an MMP9-cleavable peptide conjugate enabling targeted cytoplasmic delivery of doxorubicin. This design facilitates controlled drug release and is utilized in cancer research for studying targeted chemotherapy in both cellular and animal models.
Product Specifications
Field of Research
Immunology & Inflammation, Protein Biochemistry
Molecular Weight
897.85
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7098206-01 0.05 mg (E-Coli)
Recombinant Conus ventricosus Conotoxin VnMRCL-012
Sign In for Pricing
View Details 
MBS7098206-02 0.2 mg (E-Coli)
Recombinant Conus ventricosus Conotoxin VnMRCL-012
Sign In for Pricing
View Details MBS7098206-03 0.5 mg (E-Coli)
Recombinant Conus ventricosus Conotoxin VnMRCL-012
Sign In for Pricing
View Details 
MBS7098206-04 0.05 mg (Yeast)
Recombinant Conus ventricosus Conotoxin VnMRCL-012
Sign In for Pricing
View Details MBS7098206-05 0.05 mg (Baculovirus)
Recombinant Conus ventricosus Conotoxin VnMRCL-012
Sign In for Pricing
View Details 
MBS7098206-06 0.2 mg (Yeast)
Recombinant Conus ventricosus Conotoxin VnMRCL-012
Sign In for Pricing
View Details